Video-Assisted Instruction in Type 2 Diabetes Patients

December 12, 2023 updated by: Elif Günay İsmailoğlu, Izmir Bakircay University

The Effect of Video-Assisted Instruction in Type 2 Diabetes Patients' Insulin Self-Management and Insulin Administration Skills

The aim of the study of examine the effect of video-assisted instruction on Type 2 diabetes patients' insulin treatment self-management and insulin administration skills. The research will be conducted as a single group pre-test post-test quasi-experimental study. The sample of the study will be consisted of 50 patients with Type 2 Diabetes. Before the training, the patients will be self-injected a dose of insulin. After giving verbal training, the patients will watch a video recording of insulin treatment and administration. The author will be evaluated the patients' insulin treatment self-management and insulin administration skills after the training.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim of the study of examine the effect of video-assisted instruction on Type 2 diabetes patients' insulin treatment self-management and insulin administration skills. The research will be conducted as a single group pre-test post-test quasi-experimental study. The sample of the study will be consisted of 50 patients with Type 2 Diabetes. Before the training, the patients will be self-injected a dose of insulin. After giving verbal training, the patients will watch a video recording of insulin treatment and administration. The author will be evaluated the patients' insulin treatment self-management and insulin administration skills after the training.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Menemen
      • İzmir, Menemen, Turkey, 35160
        • Izmir Bakircay University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria

  • 18-65 years
  • No hearing or communication problems
  • Self-injecting insulin

Exclusion Criteria

  • Health care professionals
  • Chronic complications
  • Pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Video-assisted training group
The researcher will train the patients with video-assisted on insulin therapy and administration.
Patients will be given training on insulin therapy and management using lecture, question-answer, video and demonstration methods.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insulin Treatment Self-Management Scale 1 (Questionnaire)
Time Frame: Seven days after the training
Patients' self-injection practices will be evaluated.
Seven days after the training
Insulin Treatment Self-Management Scale 2 (Questionnaire)
Time Frame: Five weeks after the training
Patients' self-injection practices will be evaluated.
Five weeks after the training
Insulin Administration Observation Form 1
Time Frame: Seven days after the training
The scale identifies knowledge and skill levels of patients.
Seven days after the training
Insulin Administration Observation Form 2
Time Frame: Five weeks after the training
The scale identifies knowledge and skill levels of patients.
Five weeks after the training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2022

Primary Completion (Actual)

May 10, 2022

Study Completion (Actual)

August 10, 2023

Study Registration Dates

First Submitted

June 2, 2023

First Submitted That Met QC Criteria

June 21, 2023

First Posted (Actual)

July 3, 2023

Study Record Updates

Last Update Posted (Actual)

December 18, 2023

Last Update Submitted That Met QC Criteria

December 12, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Education, Patient

Clinical Trials on Video-assisted training

Subscribe